J. Clemmesen, I. Results from Statistical Research, The British Journal of Radiology, vol.21, issue.252, pp.583-90, 1948.
DOI : 10.1259/0007-1285-21-252-583

N. Bossard, M. Velten, and L. Remontet, Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM), European Journal of Cancer, vol.43, issue.1, pp.149-60, 2007.
DOI : 10.1016/j.ejca.2006.07.021

URL : https://hal.archives-ouvertes.fr/hal-00434567

J. Jacquemier, E. Charafe-jauffret, and G. Houvenaeghel, Cancer du sein des femmes jeunes:Existe-il un profil biopathologique different?, 32 emes journees de la SFSPM, 2010.

F. Renard, P. Vankrunkelsven, and L. Van-eycken, Decline in breast cancer incidence in the Flemish region of Belgium after a decline in hormonal replacement therapy, Annals of Oncology, vol.21, issue.12, pp.2356-2360, 2010.
DOI : 10.1093/annonc/mdq240

N. Krieger, M. Bassett, and S. Gomez, Breast and cervical cancer in 187 countries between 1980 and 2010, The Lancet, vol.379, issue.9824, pp.1391-1393, 1980.
DOI : 10.1016/S0140-6736(12)60596-0

L. Ries, D. Melbert, and M. Krapcho, National Cancer Institute, Cancer Statistics Review, 1975.

R. Dumitrescu and I. Cotarla, Understanding breast cancer risk - where do we stand in 2005?, Journal of Cellular and Molecular Medicine, vol.11, issue.1, pp.208-229, 2005.
DOI : 10.1158/1078-0432.CCR-031211

F. Bray, R. Sankila, and J. Ferlay, Estimates of cancer incidence and mortality in Europe in 1995, European Journal of Cancer, vol.38, issue.1, pp.99-166, 2002.
DOI : 10.1016/S0959-8049(01)00350-1

B. Leclere, F. Molinie, and B. Tretarre, Trends in incidence of breast cancer among women under 40 in seven European countries: A GRELL cooperative study La Situation du cancer France 2011, www.e-cancer.fr. 12. Attributable Causes of Cancer in France in the year 2000, Cancer Epidemiol. Medecine/ Science, vol.3721, issue.11, pp.544-9175, 2005.

C. Hill and F. Doyon, Frequence des cancers en France Durieux A, Caer du sei opéré d'eelée hez la feee jeue de ois de 40 as : Fateurs pronostiques de la rechute métastatique, Thèse de doctorat en médecine, pp.207-213, 2003.

K. Offit and K. Brown, Quantitating familial cancer risk: a resource for clinical oncologists., Journal of Clinical Oncology, vol.12, issue.8, pp.1724-1760, 1994.
DOI : 10.1200/JCO.1994.12.8.1724

N. Boyd, J. Byng, and R. Jong, Quantitative Classification of Mammographic Densities and Breast Cancer Risk: Results From the Canadian National Breast Screening Study, JNCI Journal of the National Cancer Institute, vol.87, issue.9, pp.670-675
DOI : 10.1093/jnci/87.9.670

T. Jacobs, J. Conolly, and S. Schnitt, Nonmalignant Lesions in Breast Core Needle Biopsies, The American Journal of Surgical Pathology, vol.26, issue.9, pp.1095-110, 2002.
DOI : 10.1097/00000478-200209000-00001

L. Lostumbo, N. Carbine, and J. Wallace, Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database of Systematic Reviews, p.2748, 2004.

D. Buist, L. Abraham, and W. Barlow, Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer, Breast Cancer Research and Treatment, vol.95, issue.3, pp.863-73, 2010.
DOI : 10.1007/s10549-010-1106-6

T. Van-sprundel, M. Schmidt, and M. Rookus, Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers, British Journal of Cancer, vol.351, issue.3, pp.287-92, 2005.
DOI : 10.1038/sj.bjc.6602703

T. Rebbeck, A. Levin, and A. Eisen, Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers, JNCI Journal of the National Cancer Institute, vol.91, issue.17, pp.1475-1484, 1999.
DOI : 10.1093/jnci/91.17.1475

T. Rebbeck, H. Lynch, and S. Neuhausen, Prevention and Observation of Surgical End Points Study Group Prophylactic oophorectomy in carriers of BRCA 1 and BRCA2 mutations, N Engl J Med, vol.336, pp.1465-71, 2002.

L. Hilakivi-clarke, Eastrogens, BRCA1, and breast cancer, Cancer Res, vol.60, pp.4993-5001, 2000.

D. Grabrick, L. Hartmann, and J. Cerhan, Risk of Breast Cancer With Oral Contraceptive Use in Women With a Family History of Breast Cancer, JAMA, vol.284, issue.14, pp.1791-98, 2000.
DOI : 10.1001/jama.284.14.1791

F. Clavel-chapelon, Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women, British Journal of Cancer, vol.8, issue.5, pp.723-730, 2002.
DOI : 10.1038/sj.bjc.6600124

URL : https://hal.archives-ouvertes.fr/inserm-00174582

A. Fabre, A. Fournier, and S. Mesrine, Progestagens Use Before Menopause and Breast Cancer Risk According to Histology and Hormone Receptors, Cancer Epidemiology Biomarkers & Prevention, vol.17, issue.10, pp.2723-2731, 2008.
DOI : 10.1158/1055-9965.EPI-08-0056

M. Stefanick, G. Anderson, and K. Margolis, Effects of Conjugated Equine Estrogens on Breast Cancer and Mammography Screening in Postmenopausal Women With Hysterectomy, JAMA, vol.295, issue.14, pp.1647-57, 2006.
DOI : 10.1001/jama.295.14.1647

G. Anderson, M. Limacher, and A. Assaf, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA, vol.291, issue.14, pp.1701-1713, 2004.

W. Chen, J. Manson, and S. Hankinson, Unopposed Estrogen Therapy and the Risk of Invasive Breast Cancer, Archives of Internal Medicine, vol.166, issue.9, pp.1027-1059, 2006.
DOI : 10.1001/archinte.166.9.1027

V. Beral, M. Women-study, and . Collaborators, Breast cancer and hormone-replacement therapy: the Million Women Study, The Lancet, vol.362, issue.9392, pp.419-446, 2003.
DOI : 10.1016/S0140-6736(03)14596-5

A. Fournier, F. Berrino, and E. Riboli, Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort, International Journal of Cancer, vol.158, issue.3, pp.448-54, 2005.
DOI : 10.1002/ijc.20710

URL : https://hal.archives-ouvertes.fr/inserm-00129104

S. La-position-de-la and . Le, Evaluation du risque et du bénéfice à travers une étude bibliographique. Conseil scientifique de la SFSPM, 2007.

T. Key, N. Allen, and E. Spencer, The effect of diet on risk of cancer, The Lancet, vol.360, issue.9336, pp.861-869, 2002.
DOI : 10.1016/S0140-6736(02)09958-0

R. Prentice, B. Caan, and R. Chlebowski, Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer, JAMA, vol.295, issue.6, pp.629-671, 2006.
DOI : 10.1001/jama.295.6.629

C. Van-gils, P. Peeters, and H. Bueno-de-mesquita, Consumption of Vegetables and Fruits and Risk of Breast Cancer, JAMA, vol.293, issue.2, pp.183-93, 2005.
DOI : 10.1001/jama.293.2.183

D. Deapen, L. Liu, and C. Perkins, Rapidly rising breast cancer incidence rates among Asian-American women, International Journal of Cancer, vol.64, issue.5, pp.747-50, 2002.
DOI : 10.1002/ijc.10415

F. Bianchini, R. Kaaks, and H. Vainio, Overweight, obesity, and cancer risk. Lancet Oncology, pp.565-74, 2002.

P. Lahmann, K. Hoffmann, and N. Allen, Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC), International Journal of Cancer, vol.131, issue.Suppl 1, pp.762-71, 2004.
DOI : 10.1002/ijc.20315

P. Lahmann, M. Schulz, and K. Hoffmann, Long-term weight change and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition Body fatness and physical activity at young ages and the risk of breast cancer in premenopausal women, Br J Cancer Br J Cancer Oct3, vol.4393, issue.937, pp.582-9817, 2005.

C. Lamar, J. Dorgan, and C. Longcope, Serum sex hormons and breast cancer risk factors in postmenopausal women, Cancer Epidemiol Biomarkers Prev, vol.12, issue.4, pp.380-383, 2003.

B. Tehard, C. Friedenreich, and J. Oppert, Effect of Physical Activity on Women at Increased Risk of Breast Cancer: Results from the E3N Cohort Study, Cancer Epidemiology Biomarkers & Prevention, vol.15, issue.1, pp.57-64, 2006.
DOI : 10.1158/1055-9965.EPI-05-0603

URL : https://hal.archives-ouvertes.fr/inserm-00107119

N. Hamajima, K. Hirose, and K. Tajima, Alcohol, tobacco and breast cancer cancer collaborative reanalysis of individuel data from 53 epidemiological studies including 58,515 women with breast cancer and 95,067 women without the disease, Br J Cancer, vol.87, issue.11, pp.1234-1279, 2002.

K. Johnson, J. Hu, and Y. Mao, The Canadian Cancer Registries Epidemiology Research Group. Passive and active smoking and breast cancer risk in Canada, 1994-97, Cancer Causes and Control, vol.11, issue.3, pp.211-232, 2000.
DOI : 10.1023/A:1008906105790

C. Gonzalez, Nutrition and cancer: the current epidemiological evidence, British Journal of Nutrition, vol.78, issue.S1, pp.42-47, 2006.
DOI : 10.1002/ijc.11671

J. Guinebretière, E. Menet, and E. Fourme, Le risque histologique, Compte Rendu du cours supérieur francophone de cancérologie, Saint paul de Vence 18-20 Janvier, 2007.

B. Sadikovic, K. Al-romaih, and J. Squire, Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer, Current Genomics, vol.9, issue.6, pp.394-408, 2008.
DOI : 10.2174/138920208785699580

P. Martin, Chapitre 3 «Cancérogénèse et tumorogénèse », Cancer du sein, 2007.

P. Martin, Phyto-estrogenes: action biologique/applications en clinique humaine. References en gynecologie obstetrique, pp.345-353, 2001.

D. Davis, H. Bradlow, and M. Wolff, Medical hypothesis: xenoestrogens as preventable causes of breast cancer, Environmental Health Perspectives, vol.101, issue.5, pp.372-77, 1993.
DOI : 10.1289/ehp.93101372

URL : http://doi.org/10.1289/ehp.93101372

F. Laden and D. Hunter, ENVIRONMENTAL RISK FACTORS AND FEMALE BREAST CANCER, Annual Review of Public Health, vol.19, issue.1, pp.101-123, 1998.
DOI : 10.1146/annurev.publhealth.19.1.101

D. Allred and D. Medina, The Relevance of Mouse Models to Understanding the Development and Progression of Human Breast Cancer, Journal of Mammary Gland Biology and Neoplasia, vol.68, issue.8, pp.279-288, 2008.
DOI : 10.1007/s10911-008-9093-5

I. Leconte, C. Feger, and C. Galant, The Importance of Radiologic Breast Density, American Journal of Roentgenology, vol.180, issue.6, pp.1675-1684, 2003.
DOI : 10.2214/ajr.180.6.1801675

T. Kolb, J. Lichy, and J. Newhouse, Comparison of the Performance of Screening Mammography, Physical Examination, and Breast US and Evaluation of Factors that Influence Them: An Analysis of 27,825 Patient Evaluations, Radiology, vol.225, issue.1, pp.165-75, 2002.
DOI : 10.1148/radiol.2251011667

E. Carpentier, A. Maruani, and P. Michenet, Can US-guided vacuum-assisted biopsies be an alternative to diagnostic surgery in cases of non diagnostic core needle bioposy, J Radiol, vol.865, issue.1, pp.475-80, 2005.

C. Balu-maestro, C. Chapellier, and P. Carrier, Imagerie dans le bilan d???extension ganglionnaire et m??tastatique du cancer du sein, Journal de Radiologie, vol.86, issue.11, pp.1649-57, 2005.
DOI : 10.1016/S0221-0363(05)81506-9

W. Knight, C. Osborne, and M. Yochmowitz, Steroid hormone receptors in breast cancer treatment strategy. Recent progress in hormon research, pp.135-158, 1980.

J. Brettes, C. Mathelin, and B. Gairard, Cancer du sein Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expressionCollege of American Pathologists guideline, Recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer, Paris. 62. Scarpin KM Nucl Recept Signal J Clin Oncol, vol.728, issue.63, pp.2784-2795, 2007.

W. Tai, R. Mahato, and K. Cheng, The role of HER2 in cancer therapy and targeted drug delivery, Journal of Controlled Release, vol.146, issue.3, pp.264-75, 2010.
DOI : 10.1016/j.jconrel.2010.04.009

F. Penault-llorca, Cancer du sein et Her 2 Brackman A, Etude epidemiologique du cancer du sein dans le sud de l'ile de la Reunion, These de doctorat en medecine, 2003.

K. Pritchard, L. Shepherd, O. Malley, and F. , and Responsiveness of Breast Cancer to Adjuvant Chemotherapy, New England Journal of Medicine, vol.354, issue.20, pp.2103-2114, 2006.
DOI : 10.1056/NEJMoa054504

I. Rubin and Y. Yarden, The Basic Biology of HER2, Annals of Oncology, vol.12, issue.suppl 1, pp.3-8, 2001.
DOI : 10.1093/annonc/12.suppl_1.S3

S. Sarkar and M. Mandal, Growth factor receptors and apoptosis regulators : signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancer. Breast Cancer: Basic and Clinical Research, pp.47-60, 2009.

P. Taneja, D. Maglic, and F. Kai, Classical and Novel Prognostic Markers for Breast Cancer and their Clinical significance. Clinical medical insights Oncology, pp.15-34, 2010.

W. Powell, D. Hicks, and N. Prescott, A New Rabbit Monoclonal Antibody (4B5) for the Immunohistochemical (IHC) Determination of the HER2 Status in Breast Cancer: Comparison With CB11, Fluorescence In Situ Hybridization (FISH), and Interlaboratory Reproducibility, Applied Immunohistochemistry & Molecular Morphology, vol.15, issue.1, pp.94-102, 2007.
DOI : 10.1097/PAI.0b013e31802ced25

D. Slamon, W. Eiermann, and N. Robert, Adjuvant Trastuzumab in HER2-Positive Breast Cancer, New England Journal of Medicine, vol.365, issue.14, pp.1273-83, 2011.
DOI : 10.1056/NEJMoa0910383

E. Romond, E. Perez, and J. Bryant, Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer, New England Journal of Medicine, vol.353, issue.16, pp.1673-84, 2005.
DOI : 10.1056/NEJMoa052122

R. Yerushalmi, R. Woods, and P. Ravdin, Ki67in breast cancer :prognostic and predictive potential, Lancet. Feb, vol.11, issue.2, pp.174-83, 2010.

S. Chang, S. Parker, and T. Pham, Inflammatory breast carcinoma incidence and survival : The SEER program of the National Cancer Institute 1975-1992. Cancer, Jun, vol.1582, issue.12, pp.2366-72, 1998.

W. Anderson, C. Kenneth, and S. Chang, Inflammatory Breast Carcinoma and Noninflammatory Locally Advanced Breast Carcinoma: Distinct Clinicopathologic Entities?, Journal of Clinical Oncology, vol.21, issue.12, pp.2254-2263, 2003.
DOI : 10.1200/JCO.2003.07.082

F. Lucas and C. Perez-mesa, Inflammatory carcinoma of the breast, Cancer, vol.68, issue.4, pp.1595-605
DOI : 10.1002/1097-0142(197804)41:4<1595::AID-CNCR2820410450>3.0.CO;2-Y

F. Baillet, C. Rozec, and L. Ucla, Treatment of Locally Advanced Breast Cancer without Mastectomy., Annals of the New York Academy of Sciences, vol.76, issue.1 Breast Cancer, pp.264-70, 1993.
DOI : 10.1111/j.1749-6632.1993.tb17217.x

C. Perez, J. Fields, and P. Fracasso, Management of locally advanced carcinoma of the breast: II. Inflammatory carcinoma, Cancer, vol.27, issue.3, pp.466-76, 1994.
DOI : 10.1002/cncr.2820741336

J. Fields, C. Perez, and R. Kuske, Inflammatory carcinoma of the breast: Treatment results on 107 patients, International Journal of Radiation Oncology*Biology*Physics, vol.17, issue.2, pp.249-55, 1989.
DOI : 10.1016/0360-3016(89)90436-7

J. Attia-sobol, J. Ferriere, and H. Cure, Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: Univariate and multivariate analysis, European Journal of Cancer, vol.29, issue.8, pp.1081-1089, 1993.
DOI : 10.1016/S0959-8049(05)80292-8

J. Rouesse, S. Friedman, and D. Sarrazin, Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy., Journal of Clinical Oncology, vol.4, issue.12, pp.1765-71, 1986.
DOI : 10.1200/JCO.1986.4.12.1765

M. Pawlicki, J. Skolyszewski, and A. Brandys, Results of combined treatment of patients with locally advanced breast cancer, Tumori, vol.69, pp.249-53, 1983.

P. Bonnier, Y. Coscas, and F. Eisinger, Prise ee harge par le hirurgiee d'ue élévation du risque du cancer du sein, 2007.
DOI : 10.1007/978-2-287-71478-8_9

J. Klijn, R. Blamey, and F. Boccardo, Combined Tamoxifen and Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Versus LHRH Agonist Alone in Premenopausal Advanced Breast Cancer: A Meta-Analysis of Four Randomized Trials, Journal of Clinical Oncology, vol.19, issue.2, pp.343-53, 2001.
DOI : 10.1200/JCO.2001.19.2.343

D. Mauri, N. Pavlidis, and N. Polyzos, Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis, JNCI Journal of the National Cancer Institute, vol.98, issue.18, pp.1285-91, 2006.
DOI : 10.1093/jnci/djj357

D. Laurentiis, M. Arpino, G. Massarelli, and E. , A meta-analysis on the interaction between HER2 expression and response to endocrine treatment in advanced breast cancer, Clin Cancer Res, vol.1113, pp.4741-4749, 2005.

R. Paridaens, L. Biganzoli, and P. Bruning, Paclitaxel Versus Doxorubicin as First-Line Single-Agent Chemotherapy for Metastatic Breast Cancer: A European Organization for Research and Treatment of Cancer Randomized Study With Cross-Over, Journal of Clinical Oncology, vol.18, issue.4, pp.724-757, 2000.
DOI : 10.1200/JCO.2000.18.4.724

J. Nabbholtz, H. Senn, and W. Bezwoda, Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy, Journal of Clinical Oncology, vol.17, issue.5, pp.1413-1437, 1999.
DOI : 10.1200/JCO.1999.17.5.1413

J. Sjostrom, C. Blomqvist, and H. Mouridsen, Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group, European Journal of Cancer, vol.35, issue.8, pp.1194-1201, 1999.
DOI : 10.1016/S0959-8049(99)00122-7

A. Berrington-de-gonzalez, C. Berq, and K. Visvanathan, Estimated Risk of Radiation-Induced Breast Cancer From Mammographic Screening for Young BRCA Mutation Carriers, JNCI Journal of the National Cancer Institute, vol.101, issue.3, pp.205-214, 2009.
DOI : 10.1093/jnci/djn440

A. Berrington-de-gonzalez and G. Reeves, Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits, British Journal of Cancer, vol.78, issue.5, pp.590-596, 2005.
DOI : 10.1054/bjoc.1999.0903

I. Baldi, D. Bard, and R. Barouki, Expertise collective Cancer et Environnement Inserm éd Identification of women with an increased risk of developing radiation-induced breast cancer, Breast Cancer Res, vol.9, issue.3, p.106, 2007.

L. Montgomery, K. Tran, and M. Heelan, Issues of Regret in Women With Contralateral Prophylactic Mastectomies, Annals of Surgical Oncology, vol.336, issue.6, pp.546-52, 1999.
DOI : 10.1007/s10434-999-0542-1

L. Hartmann, D. Schaid, and J. Woods, Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer Breast cancer screening. IARC Handbooks of Cancer Prevention, 98. Guidelines for Breast Cancer Screening: Update ( 2003) CA, pp.77-8429, 1999.

J. Michaelson, S. Satija, and R. Moore, The pattern of breast cancer screening utilization and its consequences, Cancer, vol.48, issue.1, pp.37-43, 2002.
DOI : 10.1002/cncr.10154

D. Eilstein, Z. Uhry, and R. Ancelle-park, Estimation de l'impact du depistage organise sur la mortalite par cancer du sein. Contexte, Methodologie et faisabilite, p.4, 2000.

J. Feingold, F. Eisinger, and N. Alby, Risques héréditaires de cancers du sein et de l'ovaire. Quelle prise en charge ? Expertise collective INSERM, 1998.

C. Nogues, Les prédispositions génétiques aux cancers du sein et de l'ovaire. Conséquences pratiques : peut-on donner des directives ? Cancer du sein, controverses et convergences. 21emes journees de la societe francaise de senologie et de pathologie mammaire, 1999.

F. Favier, I. Jaussent, and N. Moullec, Prevalence of Type 2 Diabetes and central adiposity in La Reunion island -Etude REDIA Cancer Incidence in five continents The NICER working group, Breast cacner incidence in younger swiss women. 2013. www.nicer.org 107 Recent trends in breast cancer incidence rates in the Loire, Diabetes Res Clin Prac. IARC scientific publications Cancer Epidemiol, vol.6734, issue.1603, pp.234-242238, 2003.

H. Swede, D. Gregorio, and S. Tannenbaum, Prevalence and Prognostic Role of Triple-Negative Breast Cancer by Race: A Surveillance Study, Clinical Breast Cancer, vol.11, issue.5, pp.332-373, 2011.
DOI : 10.1016/j.clbc.2011.04.004

F. Vicini, P. Jones, and A. Rivers, Differences in disease presentation, management techniques, treatment outcome, and toxicities in African-American women with early stage breast cancer treated with breast-conserving therapy, Cancer, vol.14, issue.14, pp.3485-92, 2010.
DOI : 10.1002/cncr.25088

G. Agarwal, P. Pradeep, and V. Aggarwal, Spectrum of Breast Cancer in Asian Women, World Journal of Surgery, vol.106, issue.1, pp.1031-1071, 2007.
DOI : 10.1007/s00268-005-0585-9

L. Brinton, M. Sherman, and J. Carreon, Recent Trends in Breast Cancer Among Younger Women in the United States, JNCI Journal of the National Cancer Institute, vol.100, issue.22, pp.1643-1651, 2008.
DOI : 10.1093/jnci/djn344

C. Anders, R. Johnson, and J. Litton, Breast Cancer Before Age 40 Years, Seminars in Oncology, vol.36, issue.3, pp.237-286, 2009.
DOI : 10.1053/j.seminoncol.2009.03.001

M. Colonna, P. Delafosse, and Z. Uhry, Is breast cancer incidence increasing among young women? An analysis of the trend in France for the period 1983???2002, The Breast, vol.17, issue.3, pp.289-92, 2008.
DOI : 10.1016/j.breast.2007.10.017

URL : https://hal.archives-ouvertes.fr/inserm-00347173

P. Cheung, W. Hung, and C. Cheung, Early Data from the First Population-Wide Breast Cancer-Specific Registry in Hong Kong, World Journal of Surgery, vol.76, issue.7, pp.723-732, 2012.
DOI : 10.1007/s00268-012-1426-2

D. Agnese, F. Yusuf, and J. Wilson, Trends in breast cancer presentation and care according to age in a single institution, The American Journal of Surgery, vol.188, issue.4, pp.437-446, 2004.
DOI : 10.1016/j.amjsurg.2004.06.029

F. Bray, P. Mccarron, and D. Parkin, The changing global patterns of female breast cancer incidence and mortality, Breast Cancer Research, vol.12, issue.20, pp.229-268, 2004.
DOI : 10.1016/S0960-9776(03)00136-X

A. Tavani, S. Gallus, L. Vecchia, and C. , Risk factors for breast cancer in women under 40 years, European Journal of Cancer, vol.35, issue.9, pp.136-143, 1999.
DOI : 10.1016/S0959-8049(99)00139-2

M. Madigan, R. Ziegler, and J. Benichou, Proportion of Breast Cancer Cases in the United States Explained by Well-Established Risk Factors, JNCI Journal of the National Cancer Institute, vol.87, issue.22, pp.1681-1686, 1995.
DOI : 10.1093/jnci/87.22.1681

A. Tavani, C. Braga, L. Vecchia, and C. , Attributable risks for breast cancer in Italy: Education, family history and reproductive and hormonal factors, International Journal of Cancer, vol.70, issue.2, pp.159-63, 1997.
DOI : 10.1002/(SICI)1097-0215(19970117)70:2<159::AID-IJC4>3.0.CO;2-W

S. Formenti, A. Arslan, and S. Love, Global Breast Cancer: The Lessons to Bring Home, International Journal of Breast Cancer, vol.103, issue.2, p.249501, 2012.
DOI : 10.1182/blood-2011-01-330332

M. Althuis, D. Brogan, and R. Coates, Breast cancers among very young premonauposal young women (Unites States), Cancer Causes and Control, vol.14, issue.2, pp.151-60, 2003.
DOI : 10.1023/A:1023006000760

N. Kroman, M. Jensen, and J. Wohlfahrt, Factors influencing the effect of age on prognosis in breast cancer: population based study Commentary: much still to learn about relations between tumour biology, prognosis, and treatment outcome in early breast cancer, BMJ, vol.320, issue.7233, pp.474-483, 2000.
DOI : 10.1136/bmj.320.7233.474

N. Andrieu, E. Barranger, and E. Bernigaud-maurice, Depistage du cancerdu sein en France: identification des femmes a haut risque et modalites de depistage

J. Elmore, L. Reisch, and M. Barton, Efficacy of Breast Cancer Screening in the Community According to Risk Level, JNCI Journal of the National Cancer Institute, vol.97, issue.14, pp.1035-1078, 2005.
DOI : 10.1093/jnci/dji183

M. Sarff, K. Schmidt, and . Vettojt, Targeted breast cancer screening in women younger than 40: results from a statewide program, The American Journal of Surgery, vol.195, issue.5, pp.626-630, 2008.
DOI : 10.1016/j.amjsurg.2007.12.044

S. Samphao, A. Wheeler, and E. Rafferty, Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging, The American Journal of Surgery, vol.198, issue.4, pp.538-581, 2009.
DOI : 10.1016/j.amjsurg.2009.06.010